Tower Research Capital (TRC)’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Tower Research Capital (TRC)’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-876	Closed	-$9K	–	6881
2022 Q3	$9K	Sell	876 -6	-0.7%	-$60	﹤0.01%	4749
2022 Q2	$9K	Sell	882 -5	-0.6%	-$50	﹤0.01%	4632
2022 Q1	$9K	Sell	887 -201	-18%	-$2K	﹤0.01%	4538
2021 Q4	$11K	Buy	1,088 +113	+12%	+$1.15K	﹤0.01%	4513
2021 Q3	$10K	Buy	975 +562	+136%	+$5.74K	﹤0.01%	4384
2021 Q2	$4K	Buy	413 +219	+113%	+$2.29K	﹤0.01%	4871
2021 Q1	$2K	Buy	194 +2	+1%	+$24	﹤0.01%	5098
2020 Q4	$2K	Buy	+192	New	+$2.06K	﹤0.01%	4946

Tower Research Capital (TRC)'s LUXAU Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q4 2022, closing a stake of 876 shares — an estimated $9K sold.

Tower Research Capital (TRC) first reported a position in LUXAU in Q4 2020 and held it in 8 quarters. The position peaked at $11K in Q4 2021. 0 funds tracked by Wall St. Rank hold LUXAU as of Q4 2022.

Tower Research Capital (TRC) reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 876 Lux Health Tech Acquisition Corp. Units shares in Q4 2022, an estimated $9K.
Tower Research Capital (TRC) first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 8 quarters.
Tower Research Capital (TRC)'s Lux Health Tech Acquisition Corp. Units position peaked at $11K in Q4 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.